iuvantium developed and launched the iPriSM™ platform to decode, predict, and control immune responses.
Published
Signal category
Products & Services
Quote
“We do this with our iPriSM™ platform that allows us to decode, predict and control immune responses.”
— iuvantium team
Company
iuvantium
iuvantium is defining the frontier of material science and immunobiology.
- Industry
- Biotechnology Research
- Location
- Oxfordshire, GB
- Company size
- 11 employees
Iuvantium is a deeptech company with a simple but radical idea: that inorganic chemistry can be used to decode and program the immune system in ways beyond what existing biology can do. Combining materials science, translational immunology, and machine learning, Iuvantium engineers inorganic nanoparticles to systematically probe the immune system across species and populations. Each experiment maps the relationship between the physicochemical properties of those materials and immune behaviour. The result is a foundation model that is used to reverse engineer the desired response into a new class of inorganic therapeutics, delivering a pipeline spanning infectious disease, immuno-oncology, and autoimmune disease, with the mission to make therapies safer and more effective for patients worldwide. Learn more at https://iuvantium.com/
Founded 2023